Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, Wegovy is a Prescription-Only Medicine (POM) in the UK. You cannot buy it over the counter, and no legitimate pharmacy will dispense it without a valid prescription from a registered prescriber. That prescription must follow a proper clinical assessment — a real clinician reviewing your health history, weight, and any relevant conditions before deciding whether Wegovy is appropriate for you. This is a legal requirement under the Human Medicines Regulations 2012, not a bureaucratic hurdle. The NHS medicines page for semaglutide is clear on this point, as is every authorised prescriber working in this area.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide is a potent medicine that affects appetite signalling, gastric emptying, and blood-sugar regulation through GLP-1 receptor pathways. It carries real contraindications (a personal or family history of medullary thyroid carcinoma, certain pancreatic conditions, and pregnancy among them) and its interactions with other medicines and individual health conditions mean it genuinely needs clinical oversight. POM status exists precisely because a prescriber needs to weigh all of that before anyone starts treatment.
There is a misconception worth addressing gently here: some people assume that because Wegovy is widely discussed online and covered in the press, it must be fairly easy to obtain informally. It is not. The prescription requirement is statutory, and the MHRA's Drug Safety Updates have repeatedly highlighted the dangers of semaglutide products sold through unverified channels. Fake pens have been found to contain insulin rather than semaglutide, a substitution with serious consequences.
The clinical review before a prescription is issued is not a formality. It considers your current BMI, any weight-related conditions you have, your medication list, and whether Wegovy is the most appropriate option for your circumstances. A prescriber may conclude that a different approach suits you better, or that certain aspects of your health history need investigation first. That judgement cannot be replicated by a questionnaire alone, and UK law does not permit it to be.
Wegovy holds a UK marketing authorisation as a treatment for weight management in adults. The licensed thresholds are a BMI of 30 or above, or a BMI of 27 to 29.9 where at least one weight-related condition is present. Common qualifying conditions include hypertension, dyslipidaemia, obstructive sleep apnoea, type 2 diabetes, and cardiovascular disease. Lower BMI thresholds can apply for some ethnic backgrounds under UK clinical guidance, typically 2.5 kg/m² below the standard figures.
Meeting those BMI numbers is a starting point, not a guarantee. The prescriber assesses the full clinical picture. Wegovy is not licensed for anyone under 18, and it is not recommended during pregnancy, while breastfeeding, or when trying to conceive. Certain medical histories require careful discussion before treatment can proceed.
NICE has also issued a recommendation (TA875) for semaglutide on the NHS, but that route carries additional criteria, including access through a specialist weight management service and a maximum treatment duration of two years. Private routes work within the licensed indication but are not subject to those NICE-specific NHS commissioning constraints. If you are weighing up the full picture for Wegovy as a treatment, it helps to understand both routes clearly before deciding.
The practical route starts with a clinical consultation. In a private setting, this typically means completing a detailed health questionnaire, with your responses reviewed by a GPhC-registered prescriber, not automated software. At nume, a clinician personally reads every consultation the same day it is submitted, and no prescription is issued without that review. Identity and weight are verified before treatment is dispatched. Our clinical team is built around that standard of oversight.
Once a prescription is issued by a qualified prescriber and the medicine is dispensed by a GPhC-registered pharmacy, it reaches you through a tracked delivery chain. You can verify any online pharmacy on the GPhC pharmacy register, it takes under a minute and is the single most reliable check you can do before handing over personal or payment details.
For people exploring the NHS route, a GP referral to a specialist weight management service is the starting point, though waiting times vary considerably by region. The step-by-step guide to getting a Wegovy prescription covers both NHS and private pathways in detail. Private treatment through a regulated pharmacy means no referral and no waiting list, subject to the prescriber's clinical assessment for a Wegovy prescription, which takes your full health history into account. The cost of private treatment is a practical question for many people, and if you are considering getting your Wegovy prescription online, a factual guide to where Wegovy is available and what to expect to pay sets out the landscape honestly.
Because Wegovy is prescription-only, any route that does not involve a real clinical assessment before dispensing is not legitimate. Red flags include sellers who ask no health questions, social media accounts offering pens for direct purchase, and pricing dramatically below the market range. Discount codes for prescription medicines from unknown sellers are another warning sign; the risks of trying to obtain Wegovy without a proper prescription are documented and serious.
The MHRA has seized millions of doses of counterfeit weight-loss medicines from illegal supply chains and investigated multiple operations producing fake tirzepatide and semaglutide pens in the UK. The clinical dangers are real. If you are uncertain about a source, the GPhC register is the definitive check. Report anything suspicious through the Yellow Card scheme, which accepts reports on both suspect medicines and suspect sellers.
If you have questions about whether you are likely to be eligible, or want to talk through your options with a prescriber, you are welcome to speak to our prescribers through a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.